Alpha Teknova Inc.
8.22
0.31 (3.92%)
At close: Jan 15, 2025, 10:39 AM

Company Description

Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally.

Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics.

The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.

It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions.

The company was founded in 1996 and is headquartered in Hollister, California.

Alpha Teknova Inc.
Alpha Teknova Inc. logo
Country United States
IPO Date Jun 25, 2021
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 210
CEO Stephen Gunstream

Contact Details

Address:
2290 Bert Drive
Hollister, California
United States
Website https://www.teknova.com

Stock Details

Ticker Symbol TKNO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001850902
CUSIP Number 02080L102
ISIN Number US02080L1026
Employer ID 94-3368109
SIC Code 2835

Key Executives

Name Position
Stephen Gunstream President, Chief Executive Officer & Director
Matthew C. Lowell Chief Financial Officer
Damon A. Terrill J.D. General Counsel, Chief Compliance Officer & Secretary
Jennifer Henry Senior Vice President of Marketing

Latest SEC Filings

Date Type Title
Nov 08, 2024 10-Q Quarterly Report
Nov 07, 2024 8-K Current Report
Aug 30, 2024 424B3 Filing
Aug 23, 2024 S-1 Filing
Aug 13, 2024 10-Q Quarterly Report
Aug 13, 2024 8-K Current Report
Jul 22, 2024 D Filing
Jul 19, 2024 SC 13D Filing
Jul 16, 2024 4 Filing
Jul 16, 2024 4 Filing